Clinical trial
Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris
NCT00372307 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00372307 |
|---|---|
| Title | Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris |
| Official title | Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris |
| Lead sponsor | University Hospital, Ghent, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitiligo Vulgaris |
| Intervention type | Drug |
| Interventions | Application of pimecrolimus |
| Enrollment | 26 |
| Start date | May 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Sep 6, 2006 |
| Last update posted | Dec 28, 2007 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: